Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Demystifying extrachromosomal DNA circles: Categories, biogenesis, and cancer therapeutics

Computational and Structural Biotechnology Journal(2022)10.1016/j.csbj.2022.10.033Source: DataRank Database

Demystifying extrachromosomal DNA circles: Categories, biogenesis, and cancer therapeutics is a research paper published in Computational and Structural Biotechnology Journal (2022). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 0.25)OA: goldTopics (22)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Kunal Rai ORCID,Manrong Wu ORCID

Live enrichment

PubMed:36382182 PMC:PMC9647416 OpenAlex:https://openalex.org/W4307904522

National Institutes of Health

Grant: R01CA222214

National Institutes of Health

Grant: R01CA226269

National Institutes of Health

Grant: R01CA245395

National Institutes of Health

Grant: R21CA256278

National Institutes of Health

Grant: 1R21CA256278-01

Contribution of Epigenome to PRKCI-Driven High-Grade Serous Ovarian Cancer

National Institutes of Health

Grant: 5R01CA222214-02

Role of KMT2D and aberrant enhancers in modulating tumor microenvironment in melanoma

National Institutes of Health

Grant: 5R01CA226269-03

Role of UBR7, a novel H2BK120 E3 ubiquitin ligase, in suppression of breast cancer

National Institutes of Health

Grant: 1R01CA245395-01A1

UCHL5 as a regulator and therapeutic target in metastatic melanoma

FWCI

0.25

Citation Percentile

0.5%

Citation Trend

2024

2025

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.csbj.2022.10.033

publisherhttps://doi.org/10.1016/j.csbj.2022.10.033

publisherhttps://api.elsevier.com/content/article/PII:S2001037022004809?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2001037022004809?httpAccept=text/plain

publisherhttps://spj.science.org/doi/pdf/10.1016/j.csbj.2022.10.033

Fields of Study

Cancer Genomics and DiagnosticsEpigenetics and DNA MethylationRNA modifications and cancer0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Extrachromosomal DNAComputational biologyBiologyBiogenesisDNAGeneticsGenomeBioinformaticsGenePhysiological responseCancer TherapeuticsEccdnasEccdna ClassificationReview ArticleTP248.13-248.65Biotechnology

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being